Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

Targeted nanomedicine holds promise to find clinical use in many medical areas.
Endothelial cells that line the luminal surface of blood vessels represent a key target for …

OBJECTIVE. This article reviews recent developments in targeted radionuclide therapy
(TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine …

Transarterial radioembolization (TARE), also called radioembolization or selective internal
radiation therapy, is an interventional radiology technique used to treat primary liver tumors …

Objective The aim of this study was to assess the early therapy response in patients with
unresectable CCA who received Y-90 microsphere therapy for CCA and define the factors …

Background: Hepatic artery infusion (HAI) is a liver-directed therapy that delivers high-dose
chemotherapy to the liver through the hepatic arterial system for colorectal liver metastases …

Simple Summary This review provides basic insights into radioembolization, also known as
selective internal radiation therapy, in patients suffering from neuroendocrine liver …

Transarterial radioembolization (TARE) with Yttrium-90 (Y90) is a growing area of study due
to its benefits in early-, intermediate-, and late-stage hepatocellular carcinoma. Treatment …

The targeted delivery of anti-cancer drugs and isotopes is one of the most pursued goals in
anti-cancer therapy. One of the prime examples of such an application is the intra-arterial …

Purpose To quantify the relationship of the tumor-to-normal ratio (TNR) attained from the
technetium-99m macroaggregated albumin (MAA) and posttreatment yttrium-90 …